… Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular
implications. Eur Respir J 1995; 8: 222-9. [96] Carlson JT, Hedner J, Elam M, Ejnell H, …

… that mortality is increased in untreated OSAS patients. In this review, we examine the link
between OSAS and cardiovascular morbidity and mortality. … hypertension, cardiac arrhythmias, …

… of weight loss on the cardiovascular co-morbidities of obesity. … discussion: the effect of CPAP
treatment and weight loss on … combined MI recurrence and cardiac mortality rate was 4.07 …

… apnea and co-morbidities in males and females” and (2) “obstructive sleep apnea and co-morbidities …
impact of OSA on cardiovascular and non-cardiovascular mortality in both genders …

… of mortality in patients with CAD independent of age and traditionally recognized risk factors.
CPAP treatment … The treatment related reversal of the enhanced vascular response to AT2 …

… longer CPAP treatment, Martinez et al. found that CPAP treatment in older patients decreased
cardiovascular mortality … In our study, we found that CPAP treatment was associated with a …

… CPAP treatment and decreased cardiovascular mortality risk. Adherence to … with cardiovascular
mortality in women and that CPAP treatment is associated with a decrease in mortality …

… Therefore, the objective of our study was to analyze the impact of OSA and CPAP treatment
on cardiovascular mortality in a large range of individuals of both sexes, all at least 65 years …

… We also evaluated the effects of CPAP treatment on all-cause and cardiovascular mortality
of OSA patients. Effective CPAP treatment was defined based on an average cumulative …

… treatment of obstructive sleep apnea and the effects of treatment on cardiovascular morbidity
… inflammation that are associated with increased cardiovascular risk. The primary markers …